Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Thrombosomes in Acute Thoracic Aortic Dissections
NCT05771831Phase 2Completed
- Sponsor
- Jakob Stensballe
- Start
- Mar 2023
- Primary completion
- Apr 2024
- Modality
- Cell Therapies
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of Thrombosomes in hemorrhage (2 arms), sponsored by Jakob Stensballe. Primary endpoint: Time to hemostasis during surgery. Started Mar 2023; status: completed.
02
Drugs
Thrombosomes
03
Conditions
hemorrhage
Beyond the preview
Go deeper on NCT05771831.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05771831.